H. Chapel

发表

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

P. Bain, A. Vincent, J. Newsom-Davis, 1996, Neurology.

Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia.

P. A. Lawrence, S. Misbah, H. Chapel, 1991, Postgraduate medical journal.

Polycystic parotid disease in a male child: report of a case and review of the literature.

H. Chapel, K. Eley, S. Golding, 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

Davis J. McCarthy, Calliope A. Dendrou, Lisa J. Murray, 2015, Nature Genetics.

Pyogenic Bacterial Infections in Humans with MyD88 Deficiency

J. Banchereau, D. Chaussabel, J. Casanova, 2003, Science.

Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011

H. Chapel, 2012, Clinical and experimental immunology.

Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides

H. Chapel, H. Chapel, W. Egner, 1990, Clinical and experimental immunology.

Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles.

T. Kuijpers, H. Chapel, A. Verhoeven, 2009, Molecular immunology.

variants in antibody deficiency syndromes TNFRSF13B distinguishing disease-causing from risk-increasing mutations in TNFRSF13B Relevance of biallelic versus monoallelic

Anna L. David, A. Schäffer, E. Gertz, 2009 .

Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

A. Schäffer, E. Gertz, A. Plebani, 2008, Blood.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI

S. Watson, D. Nelson, H. Chapel, 1999 .

HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Regulation and Function of WASp in Platelets by the Collagen Receptor , Glycoprotein

S. Watson, D. Nelson, H. Chapel, 1999 .

Direct Ex-Vivo Evaluation of Pneumococcal Specific T-Cells in Healthy Adults

G. Ogg, H. Chapel, A. Aslam, 2011, PloS one.

European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries.

H. Chapel, A. Giovannetti, I. Quinti, 2002, Clinical immunology.

CLINICAL RELEVANCE OF SPECIFIC IgG ANTIBODIES TO CARDIOLIPIN

H. Chapel, J. Faux, M. Byron, 1989, The Lancet.

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

D. Adu, S. Misbah, H. Chapel, 2000, QJM : monthly journal of the Association of Physicians.

The EUROclass trial: defining subgroups in common variable immunodeficiency.

Eren, M. Vihinen, M. Vlková, 2008, Blood.

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Lennart Hammarstrom, B. Grimbacher, M. Abedi, 2008, Blood.

Dysphagia associated with anti‐PM‐Scl antibodies in systemic lupus erythematosus

H. Chapel, G. Maidment, R. Borrows, 2006, Scandinavian journal of rheumatology.

Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents

H. Chapel, 1999, Clinical and experimental immunology.

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach

J. Litzman, H. Chapel, S. Jolles, 2017, Clinical and experimental immunology.

Key stages of bone marrow B-cell maturation are defective in patients with common variable immunodeficiency disorders.

Smita Y. Patel, M. van der Burg, E. López-Granados, 2015, The Journal of allergy and clinical immunology.

Intravenous immunoglobulin in neurological disease: a specialist review

R. Hughes, M. Rose, J. Palace, 2002, Journal of neurology, neurosurgery, and psychiatry.

Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A

R. Davies, F. Gleeson, H. Chapel, 2000, Thorax.

Unusual case presentations associated with the CD45 C77G polymorphism

B. Ferry, H. Renz, S. Misbah, 2006, Clinical and experimental immunology.

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma

H. Chapel, M. Lee, A. Prentice, 1994, The Lancet.

Protocol for the unclassified primary antibody deficiency (unPAD) study: Characterization and classification of patients using the ESID online Registry

H. Chapel, E. de Vries, Ineke G M Reijnen, 2022, PloS one.

Letter: Rosette inhibition in Graves's disease.

H. Chapel, J. R. Batchelor, 1974, The New England journal of medicine.

Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

A. Fischer, L. Fugger, E. López-Granados, 2011, Blood.

Intravenous immune globulin in chronic lymphocytic leukaemia.

F. Ries, H. Chapel, M. Lee, 1994, Clinical and experimental immunology.

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

A. Fischer, E. Cirillo, A. Plebani, 2011, Blood.

The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index

S. Sánchez-Ramón, N. Mahlaoui, H. Chapel, 2021, Frontiers in Immunology.

The International Union of Immunological Societies (IUIS) Primary Immunodeficiency Diseases (PID) Classification Committee

A. Fischer, J. Casanova, L. Notarangelo, 2008 .

Class III HLA Genes and Systemic Lupus Erythematosus

D. Isenberg, M. Snaith, G. Hughes, 1986 .

Immunological factors and risk of infection in plateau phase myeloma.

H. Chapel, M. Lee, J. Lea, 1995, Journal of clinical pathology.

COMPLEMENT SYSTEM PROTEIN C4 AND SUSCEPTIBILITY TO HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS

H. Chapel, J. R. Batchelor, A. Fielder, 1989, The Lancet.

Immunomodulatory Therapy to Achieve Maximum Efficacy: Doses, Monitoring, Compliance, and Self-infusion at Home

S. Misbah, H. Chapel, P. Spaeth, 2010, Journal of Clinical Immunology.

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor

Smita Y. Patel, É. Oksenhendler, S. Chevret, 2013, Clinical and experimental immunology.

Histology of Interstitial Lung Disease in Common Variable Immune Deficiency

Smita Y. Patel, F. Dhalla, Smita Y Patel, 2020, Frontiers in Immunology.

International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

C. Cunningham-Rundles, M. Tang, F. Bonilla, 2016, The journal of allergy and clinical immunology. In practice.

Current Perspectives ICON : Common Variable Immunodeficiency Disorders

C. Cunningham-Rundles, F. Bonilla, S. Nonoyama, 2015 .

Lymphoid Proliferations of Indeterminate Malignant Potential arising in Adults with Common Variable Immunodeficiency Disorders: Unusual Case Studies and Immunohistological Review in the Light of Possible Causative Events

Smita Y. Patel, E. Jaffe, C. Cunningham-Rundles, 2011, Journal of Clinical Immunology.

Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions

C. Cunningham-Rundles, H. Chapel, 2009, British journal of haematology.

Granulomatous disease: distinguishing primary antibody disease from sarcoidosis.

C. Cunningham-Rundles, S. Misbah, H. Chapel, 2008, Clinical immunology.

Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review

S. Stanworth, H. Chapel, C. Hyde, 2007, Clinical and experimental immunology.

Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE

Smita Y. Patel, Anne-Kathrin Kienzler, Jenny C. Taylor, 2016, Clinical immunology.

Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells

A. Fischer, J. Casanova, C. Picard, 2008, The Journal of experimental medicine.

Primary immunodeficiency diseases: an update

R. Geha, F. Rosen, H. Chapel, 2003, Clinical and experimental immunology.

Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population

R. Callard, D. Kumararatne, H. Chapel, 2005, Journal of Virology.

Burden of copy number variation in common variable immunodeficiency

Joseph T. Glessner, J. Glessner, H. Hakonarson, 2014, Clinical and experimental immunology.

A mutation in X‐linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein–Barr virus‐specific T cells

P. Klenerman, E. López-Granados, Anne-Kathrin Kienzler, 2014, Clinical and experimental immunology.

Anti‐granulocyte opsonic activity in sera from patients with systemic lupus erythematosus

H. Chapel, H. Chapel, A. Holburn, 1987, British journal of haematology.

A preliminary assessment of alpha‐1 antitrypsin S and Z deficiency allele frequencies in common variable immunodeficiency patients with and without bronchiectasis

B. Ferry, H. Chapel, M. Sansom, 2002, Clinical and experimental immunology.

Primary immunodeficiency diseases: an update.

J. Casanova, L. Notarangelo, R. Geha, 2004, The Journal of allergy and clinical immunology.

Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.

H. Chapel, 1994, BMJ.

Primary antibody deficiency in adults

S. Misbah, H. Chapel, G. Spickett, 1991, The Lancet.

The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies

W. Sewell, H. Chapel, M. Donaghy, 1997, Journal of neurology, neurosurgery, and psychiatry.

Adverse Effects of Intravenous Immunoglobulin

S. Misbah, H. Chapel, 1993, Drug safety.

Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts.

Smita Y. Patel, C. Cunningham-Rundles, É. Oksenhendler, 2012, The Journal of allergy and clinical immunology.

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

E. López-Granados, S. Misbah, H. Chapel, 2010, The Journal of allergy and clinical immunology.

The use of rheumatoid factors in clinical practice.

H. Chapel, M. Webley, A. Adebajo, 1995, Postgraduate medical journal.

Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

Douglas R. McDonald, A. Al-ghonaium, Sami Al-Hajjar, 2010, Medicine.

Toll-Like Receptor Responses in IRAK-4-Deficient Neutrophils

T. K. van den Berg, T. Kuijpers, H. Chapel, 2009, Journal of Innate Immunity.

Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients

R. Schmidt, A. Plebani, J. Litzman, 2013, Clinical and experimental immunology.

Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID).

J. Farrant, H. Chapel, G. Spickett, 1994, Immunodeficiency.

Mechanisms of infection in chronic lymphocytic leukemia.

H. Chapel, C. Bunch, Chapel Hm, 1987, Seminars in hematology.

Lymphoproliferative disease in antibody deficiency: a multi‐centre study

H. White, B. Angus, M. Gompels, 2003, Clinical and experimental immunology.

Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases

Constantin Polychronakos, Yiran Guo, Dong Li, 2016 .

Immunoglobulin replacement therapy by self-infusion at home.

H. Chapel, V. Brennan, E. Delson, 1988, Clinical and experimental immunology.

A Fast Procedure for the Detection of Defects in Toll-like Receptor Signaling

J. Casanova, C. Picard, H. von Bernuth, 2006, Pediatrics.

How Common Variable Immune Deficiency has Changed Over Six Decades

C. Cunningham-Rundles, H. Chapel, 2014 .

Primary immune deficiencies − improving our understanding of their role in immunological disease

H. Chapel, H. M. Chapel, 2005, Clinical and experimental immunology.

Comprar Essentials Of Clinical Immunology 6th Ed. | Helen Chapel | 9781118472958 | Wiley

N. Snowden, S. Misbah, H. Chapel, 2014 .

Long‐term outcomes of 176 patients with X‐linked hyper‐IgM syndrome treated with or without hematopoietic cell transplantation

L. Notarangelo, J. Chou, C. Cunningham-Rundles, 2017, The Journal of allergy and clinical immunology.

Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review

E. Moxon, S. Misbah, H. Chapel, 1992, Journal of Clinical Immunology.

Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?

C. Mullighan, S. Weston, S. Weston, 2001, Clinical and experimental immunology.

Does 77→G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?

B. Ferry, J. Královičová, I. Vořechovský, 2001, Nature Genetics.

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005.

A. Fischer, J. Casanova, L. Notarangelo, 2006, The Journal of allergy and clinical immunology.

HTAs and access to rare diseases therapies: How can clinicians assist in the healthcare assessment of treatments for patients with primary immune deficiencies?

H. Chapel, 2011 .

Manual of clinical laboratory immunology, 4th edition: edited by M.R. Rose, E. Conway de Macario, J.L. Fahey, H. Friedman and G.M. Penn, American Society for Microbiology, 1992. $89.00 (xxv + 987 pages) ISBN 55581 043 8

H. Chapel, M. Browning, Mike Browning, 1993 .

Primary Immune Deficiencies – Principles of Care

F. Bonilla, H. Chapel, H. Gaspar, 2014, Front. Immunol..

Primary immune - principles of care.

F. Bonilla, H. Chapel, H. Gaspar, 2014 .

Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease

Smita Y. Patel, R. Sadler, B. Ferry, 2014, Journal of Clinical Immunology.

The Comparison of the Efficacy and Safety of Intravenous Versus Subcutaneous Immunoglobulin Replacement Therapy

D. Ericson, M. Eibl, H. Chapel, 2000, Journal of Clinical Immunology.

Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?

Smita Y. Patel, F. Dhalla, Smita Y Patel, 2014, Journal of Clinical Immunology.

Dissecting the group of common variable immunodeficiency disorders.

H. Chapel, A. Aslam, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Novel Mutation in a Patient with a Deficiency of the Eighth Component of Complement Associated with Recurrent Meningococcal Meningitis

B. Ferry, H. Chapel, B. Morgan, 2009, Journal of Clinical Immunology.

A. Fischer, E. López-Granados, E. Mejstrikova, 2011, Blood.

Antipolysaccharide antibodies in 450 children with otitis media

T. Mitchell, S. Misbah, H. Chapel, 1997, Clinical and experimental immunology.

CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome.

A. Villa, M. Vihinen, S. Giliani, 1996, Immunology today.

Diagnostic Immunology Laboratory Manual

H. Chapel, 1992 .

Subcutaneous immunoglobulin replacement therapy: the European experience

A N N Gardulf, H. Chapel, 2013, Current opinion in allergy and clinical immunology.

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.

P. Simmonds, R. Chapman, K. Fleming, 1996, Gastroenterology.

Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy.

H. Chapel, M. Bhole, J. Burton, 2008, Immunology and allergy clinics of North America.

Primary immunodeficiencies: 2009 update.

A. Fischer, J. Casanova, L. Notarangelo, 2009, The Journal of allergy and clinical immunology.

Alopecia totalis and vitiligo in common variable immunodeficiency.

H. Chapel, A. Prentice, T. Wallington, 1991, Postgraduate medical journal.

Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders

Smita Y. Patel, J. Knight, Anne-Kathrin Kienzler, 2015, Clinical immunology.

A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency.

S. Misbah, H. Chapel, J. Faux, 1992, Journal of immunological methods.

Essentials of clinical immunology

H. Chapel, 1984 .

Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency.

K. Talbot, S. Misbah, H. Chapel, 2004, Clinical immunology.

Recurrent intra-cranial granulomata presenting as space-occupying lesions in a patient with common variable immunodeficiency.

M. Esiri, R. Thompson, S. Misbah, 1992, Postgraduate medical journal.

Fortnightly Review: Concensus on diagnosis and management of primary antibody deficiencies

H. Chapel, 1994 .

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.

Shigeaki Nonoyama, Mary Ellen Conley, Luigi D Notarangelo, 2007, The Journal of allergy and clinical immunology.

The use of intravenous immune globulin in multiple myeloma.

H. Chapel, M. Lee, Helen Chapel, 1994, Clinical and experimental immunology.

Chronic mucocutaneous candidiasis: characterization of a family with STAT‐1 gain‐of‐function and development of an ex‐vivo assay for Th17 deficiency of diagnostic utility

Smita Y. Patel, J. Knight, R. Sadler, 2016, Clinical and experimental immunology.

Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency

A. Fischer, J. Casanova, L. Notarangelo, 2011, Front. Immun..

Human cytomegalovirus infection is not increased in common variable immunodeficiency

K. Welsh, H. Chapel, J. Kurtz, 1996, Journal of Clinical Immunology.

Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C.

R. Chapman, H. Chapel, J. Christie, 2001, Clinical immunology.

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial.

K. Foon, K. Rai, R. Gale, 1988, The New England journal of medicine.

The ratio of mean daily IgG increment/mean daily dose in immunoglobulin replacement therapy in primary antibody deficiencies.

É. Oksenhendler, H. Chapel, M. Lee, 2015, The journal of allergy and clinical immunology. In practice.

Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme

S. Travis, F. Dhalla, H. Chapel, 2011, Clinical and experimental immunology.

Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity

Douglas R. McDonald, A. Al-ghonaium, Sami Al-Hajjar, 2007, The Journal of experimental medicine.

Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up

R. Chapman, K. Fleming, M. Duddridge, 1997, Clinical and experimental immunology.

Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease

Smita Y. Patel, R. Xavier, S. Kugathasan, 2016, Gut.

Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency

H. Chapel, H. Gaspar, K. Gilmour, 2004, Clinical and experimental immunology.

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Lymphoproliferative Syndrome With Autoimmunity: A Possible Genetic Basis for Dominant Expression of the Clinical Manifestations

F. Rieux-Laucat, A. Fischer, F. Deist, 2022 .

Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.

J. Litzman, S. Strobel, H. Chapel, 1996, Archives of disease in childhood.

Genetic sharing and heritability of paediatric age of onset autoimmune diseases

Hongzhe Li, Constantin Polychronakos, Yiran Guo, 2015, Nature Communications.

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review

F. Ries, H. Chapel, M. Lee, 1991, Cancer.

Use of Intravenous Immunoglobulin in Chronic Lymphocytic Leukemia

Martin L. Lee, F. Ries, H. Chapel, 1991 .

Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe

W. Sewell, T. Kuijpers, M. Eibl, 2014, Front. Immunol..

Immunoglobulin replacement therapy for primary immunodeficiencies.

J. Peter, H. Chapel, 2014, Immunotherapy.

Human TLR-7-, -8-, and -9-Mediated Induction of IFN-α/β and -λ Is IRAK-4 Dependent and Redundant for Protective Immunity to Viruses

A. Al-ghonaium, Sami Al-Hajjar, J. Casanova, 2005, Immunity.

Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency.

J. Casanova, C. Picard, H. von Bernuth, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia

H. Chapel, J. Collier, J. Piris, 2008, Clinical and experimental immunology.

Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus

R. Chapman, H. Chapel, W. Rosenberg, 1999, Hepatology.

Hepatitis C after intravenous immunoglobulin.

W. Sewell, H. Chapel, C. Mullighan, 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Anti‐granulocyte opsonic activity and autoimmune neutropenia

H. Chapel, A. Holburn, A. Hadley, 1986, British journal of haematology.

NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders

E. López-Granados, J. Litzman, B. Ferry, 2010, Clinical and experimental immunology.

Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

A. Schäffer, J. Rockstroh, Q. Pan-Hammarström, 2005, Nature Genetics.

Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.

Smita Y. Patel, A. Fischer, J. Hugot, 2014, The Journal of allergy and clinical immunology.

Europe Immunoglobulin Map

A. Šedivá, A N N Gardulf, H. Chapel, 2014, Clinical and experimental immunology.

A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside

J. Casanova, L. Notarangelo, R. Geha, 2013, Journal of Clinical Immunology.

Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method

B. Ferry, K. Warnatz, H. Peter, 2005, Clinical and experimental immunology.

Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy

F. Dhalla, S. Sánchez-Ramón, H. Chapel, 2016, Front. Immunol..

Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases.

H. Chapel, G. Spickett, T. Askew, 1995, Quality in health care : QHC.

Combined familial C7 and C4B deficiency in an adult with meningococcal disease.

R. Thompson, H. Chapel, J. R. Batchelor, 1987, Clinical and Experimental Immunology.

Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells

Christian Gieger, Torsten Witte, Bodo Grimbacher, 2015, Nature Communications.

Report of nine cases of accidental injury to man with Freund's complete adjuvant.

H. Chapel, P. J. August, 1976, Clinical and experimental immunology.

Secondary immunodeficiency in lymphoproliferative malignancies

F. Dhalla, H. Chapel, O. Winqvist, 2016, Hematological oncology.

Rare variants at 16p11.2 are associated with common variable immunodeficiency.

Joseph T. Glessner, J. Glessner, H. Hakonarson, 2015, The Journal of allergy and clinical immunology.

Cholangiocarcinoma Complicating Secondary Sclerosing Cholangitis from Cryptosporidiosis in an Adult Patient with CD40 Ligand Deficiency: Case Report and Review of the Literature

R. Chapman, H. Chapel, Monira Rahman, 2012, International Archives of Allergy and Immunology.

Common Variable Immunodeficiency Disorders (CVID) - Diagnoses of Exclusion, Especially Combined Immune Defects.

H. Chapel, 2016, The journal of allergy and clinical immunology. In practice.

Defining B cell defects and correlation with complications in Common Variable Immune Deficiency patients.

Smita Y. Patel, H. Chapel, 2019, The Journal of allergy and clinical immunology.

Defining B-cell defects and correlation with complications in patients with common variable immune deficiency

H. Chapel, 2019 .

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes

F. Ries, H. Chapel, M. Lee, 1994, British journal of haematology.

Current practice and future directions in clinical immunology.

H. Chapel, R. Barnes, 1995, Journal of the Royal Society of Medicine.

Rapid effector function of circulating CD4+ T cells specific for immunodominant regions of the conserved serine/threonine kinase found in Streptococcus pneumoniae (StkP) in healthy adults.

G. Ogg, L. Nováková, P. Branny, 2010, FEMS immunology and medical microbiology.

Immune deficiencies , infection , and systemic immune disorders Genome-wide association identifies diverse causes of common variable immunodeficiency

Joseph T. Glessner, J. Glessner, H. Hakonarson, 2011 .

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors

H. Chapel, M. Lee, J. Lea, 1989 .

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.

H. Chapel, M. Lee, J. Lea, 1989, Blood.

Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk–benefit assessment for immunoglobulin treatment

N. Evangelou, P. Anslow, H. Chapel, 2003, Journal of clinical pathology.

Predictors of infection in chronic lymphocytic leukaemia (CLL)

H. Chapel, M. Lee, J. Lea, 1992, Clinical and experimental immunology.

Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.

R. Thompson, P. Yap, H. Chapel, 1983, Clinical and experimental immunology.

Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): Kinetics of immunoglobulin metabolism

H. Chapel, M. Lee, 2004, Journal of Clinical Immunology.

Diphtheria, pertussis, and tetanus vaccination

E. Moxon, H. Chapel, R. Booy, 1992, The Lancet.

Comparison of American and European practices in the management of patients with primary immunodeficiencies

J. Orange, L. Notarangelo, B. Grimbacher, 2012, Clinical and experimental immunology.

Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus.

H. Chapel, M. Allington, S. Cederholm-Williams, 1987, Annals of the rheumatic diseases.

T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections

R. Sadler, B. Ferry, D. Harrison, 2012, Clinical and experimental immunology.

IVIG indications in patients with chronic lymphocytic leukaemia

H. Chapel, 1992 .

A study of the aetiology of gastritis following gastric surgery. I. Immunofluorescent studies of the gastric mucosa.

H. Chapel, A. Hoare, 1979, Clinical and experimental immunology.

Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients

H. Chapel, M. Lee, M. Lunn, 2015, Clinical and experimental immunology.

Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials

S. Misbah, H. Chapel, S. Jolles, 2017, Journal of Clinical Immunology.

Clinical challenges in the management of patients with B cell immunodeficiencies

H. Chapel, J. Hodkinson, 2017, Clinical and experimental immunology.

Diminished Thyroxine-Binding Globulin in Pubertal Diabetic Children

D. Dunger, I. Jefferson, H. Chapel, 1996, Diabetes Care.

Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita.

H. Chapel, F. Wojnarowska, U. Tayal, 2008, Clinical immunology.

Impaired Antibody Affinity Maturation Process Characterizes a Subset of Patients with Common Variable Immunodeficiency1

D. Bonhomme, P. Romeo, L. Hammarström, 2000, The Journal of Immunology.

Prescribing intravenous immunoglobulin: summary of Department of Health guidelines

W. Sewell, H. Chapel, D. Provan, 2008, BMJ : British Medical Journal.

A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside

A. Fischer, J. Casanova, L. Notarangelo, 2013, Journal of Clinical Immunology.

Common Variable Immunodeficiency Process Characterizes a Subset of Patients Impaired Antibody Affinity Maturation

F. Deist, D. Bonhomme, P. Romeo, 2000 .

Clinical immunology : a practical approach

H. Chapel, H. Gooi, 1990 .

ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children.

H. Chapel, J. Faux, K. Windebank, 1987, Journal of immunological methods.

Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?

H. Chapel, C. Anzilotti, M. Lucas, 2019, Clinical and experimental immunology.

Chest Complications in Patients with Primary Antibody Deficiency Syndromes (PADS)

Smita Y. Patel, H. Chapel, C. Anzilotti, 2018, Humoral Primary Immunodeficiencies.

Attempt to reverse atrophic gastritis associated with common variable immunodeficiency.

P. I. Reed, S. Misbah, H. Chapel, 1992, Journal of clinical gastroenterology.

Intravenous immunoglobulin and hepatitis C virus: the British episode.

H. Chapel, C. Healey, 1996, Clinical Therapeutics.

Treatment of acute hepatitis C with alpha interferon in hypogammaglobulinaemia - the UK gammagard outbreak

K. Fleming, N. Snowdon, H. Chapel, 1995 .

OUTBREAK OF ACUTE HEPATITIS-C FOLLOWING INTRAVENOUS IMMUNOGLOBULIN THERAPY

P. Simmonds, R. Chapman, K. Fleming, 1994 .

Mutations in TACI are associated with immunodeficient phenotypes in humans.

A. Schäffer, Q. Pan-Hammarström, L. Hammarström, 2005 .

Immunology of Human Infection: Part 2 'Viruses and parasites: diagnosis and prevention of infectious diseases'

H. Chapel, 1984 .

Self-infusion with immunoglobulin at home.

H. Chapel, V. Brennan, 1991, Journal of clinical pathology.

Clinical Immunology Update—Reviews for Physicians

H. Chapel, 1984 .

Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

Douglas R. McDonald, A. Al-ghonaium, Sami Al-Hajjar, 2010 .

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Lennart Hammarstrom, B. Grimbacher, M. Abedi, 2008, Blood.

Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group

V. Lougaris, A. Plebani, G. Driessen, 2018, Journal of Clinical Immunology.

Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI

S. Watson, D. Nelson, H. Chapel, 1999 .

HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Regulation and Function of WASp in Platelets by the Collagen Receptor , Glycoprotein

D. Nelson, H. Chapel, J. Wilde, 1999 .

Progressive multifocal leucoencephalopathy, sclerosing cholangitis, bronchiectasis and disseminated warts in a patient with primary combined immune deficiency.

M. Esiri, S. Misbah, H. Chapel, 1992, Journal of clinical pathology.

What are immunodeficiencies

H. Chapel, P. Arkwright, Helen Chapel, 2008 .

Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency

J. Casanova, L. Notarangelo, R. Geha, 2014, Front. Immunol..

Lymphocyte subset reference ranges in adult Caucasians.

D. Jewell, T. Reichert, M. DeBruyère, 1991, Clinical immunology and immunopathology.

Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI

S. Watson, D. Nelson, H. Chapel, 1999 .

Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions

C. Cunningham-Rundles, H. Chapel, 2009, British journal of haematology.

Rare variants at 16p11.2 are associated with common variable immunodeficiency.

J. Glessner, H. Hakonarson, Cecilia Kim, 2015, The Journal of allergy and clinical immunology.

Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

Douglas R. McDonald, A. Al-ghonaium, Sami Al-Hajjar, 2010, Medicine.

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

A. Fischer, E. Cirillo, A. Plebani, 2011, Blood.

Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients

H. Chapel, M. Lunn, M. Lee, 2015, Clinical and experimental immunology.

IVIG indication in patients with low-grade B-cell tumors

H. Chapel, H. Griffiths, Martin L. Lee, 1991 .

Patients' views on subcutaneous IgG (SCIG) Home Therapy: results from The UK Subgam ® Study.

M. Duddridge, P. Williams, A. Exley, 2000 .

Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients

R. Schmidt, A. Plebani, J. Litzman, 2013, Clinical and experimental immunology.

Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group

V. Lougaris, A. Plebani, G. Driessen, 2018, Journal of Clinical Immunology.

Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.

H. Chapel, E. Sim, J. R. Batchelor, 1987, Clinical and experimental immunology.

Clinical Immunology—A Physician's Guide

H. Chapel, 1983 .

529 The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

D. Ericson, M. Eibl, H. Chapel, 2000 .